Resveratrol has gained tremendous interest owing to multiple reported healthbeneficial effects. However, the underlying key mechanism of action of resveratrol remained largely controversial. Here, we demonstrate that under physiologically relevant conditions major biological effects of resveratrol can be attributed to the generation of oxidation products such as reactive oxygen species (ROS). At low hormetic concentrations (< 50 µM), treatment with resveratrol increased cell viability in a set of representative cell models, whereas application of quenchers of ROS completely truncated these beneficial effects. Notably, application of resveratrol led to mild, Nrf2-specific cellular gene expression reprogramming. For example, in primary human epidermal keratinocytes this resulted in a 1.3-fold increase of endogenous metabolites such as gluthathione (GSH) and subsequently in a quantitative reduction of the cellular redox environment by 2.61 mV mmol GSH (g protein) -1 . In particular in resveratrol pre-treated cells, after external application of oxidative stress by using 0.8 % ethanol, endogenous ROS generation was consequently reduced by 24 %. In contrast to the common perception that resveratrol acts mainly as a chemical antioxidant or as a target protein-specific ligand, we propose that effects from resveratrol treatment are essentially based on oxidative triggering of cells. In relevant physiological microenvironments this effect can lead to hormetic shifting of cellular defence towards a more reductive state to improve resilience to oxidative stress in a manner that can be exactly defined by the redoxenvironment of the cell.
Introduction
Polyphenols represent a large collection of natural products featuring healthbeneficial effects 1 . Resveratrol (3, 5, 4 '-trihydroxy-trans-stilbene, RSV), an antimicrobial phytoalexin originally found in white hellebore (Veratrum grandiflorum O Loes) and later in red grapes and other plants, is one of the most prominent polyphenols. Early studies indicated cancer chemo-preventive properties of RSV 2 .
Over the last 15 years, numerous studies claimed additional benefits including cardioprotective and anti-aging effects 3 . Consequently, a number of products based on RSV have been developed for dietary and dermatological application 4, 5 . Nevertheless, the efficiencies of RSV treatments and underlying mechanisms of action remained largely controversial. For example, RSV had been suggested to modulate estrogen receptor activity 6 , or act as a caloric mimetic by directly increasing the enzymatic activity of the histone deacetylase sirtuin 1 (SIRT1) 7 . Recently, it was shown that inhibition of phosphodiesterase 4 (PDE4) by RSV increased intracellular amounts of the hunger signalling molecule cAMP 8 . Notably, the reported interaction of RSV with these and further target proteins were in many cases low and unspecific (mostly in the mid micromolar range). In general, most of these studies assumed a proportional doseresponse relationship of compounds, i.e. a conventional pharmacological (linear) threshold model 9 .
However, in contrast to the standard pharmacological model, hundreds of studies reported (unconsciously) beneficial effects of RSV at "low" but detrimental outcomes at "high" doses. Nevertheless, this potentially counterintuitive bi-phasic property of RSV was widely ignored 10 . The large body of these data would hint to hormesis, a dose-response relationship that is characterized by low-dose stimulation and highdose inhibition, consistent with the Arndt-Schulz law, Hueppe's rule and other terms describing a beneficial stimulation (of poisons) at low doses 11, 12 . General acceptance of the hormesis concept for therapeutic application seems to remain low, due to the generally low stimulatory effects and particularly due to an often lacking mechanistic explanation of the underlying mode of action of so-called hormetic compounds.
Interestingly, polyphenols including RSV are considered as antioxidants. But depending on the chemical context RSV and other polyphenols can also become pro-relatively stable 4'-phenoxyl radical, which can produce reactive oxygen species (ROS) 13, 14 . (Auto-) oxidative reactions of polyphenols are influenced by changing pH, particularly the presence of hydroxyl anions or organic bases 15, 16 . Additionally, metal ions (e.g. iron II ions) facilitate oxidative reactions and further radical generation via Fenton reactions 17 .
This study aimed to connect fragmented pieces of the chemical and resulting biological properties of RSV to provide a conceptually comprehensive mechanistic understanding of the varying purported health-beneficial effects of RSV.
Results and Discussion

RSV is unstable under physiologically relevant conditions
The vast majority of studies seem to assume specific RSV-target protein interactions, which implies that RSV remains intact during treatments. However, after incubation in various media containing physiological concentrations of sodium bicarbonate Table S1 ). After 16 hours incubation the absorption maximum of RSV was almost completely diminished. Furthermore, using a commonly applied fluorescence-based SIRT1 assay no enzymatic activation could be detected (Fig. S1e ).
Oxidation of resveratrol at atmospheric oxygen level (21% O 2 , as usually applied in cell culture) 16 ,18 could potentially be considered as non-physiological (in blood vessels the oxygen amount is roughly 14% and in tissues or tumours even lower (~ 1% O 2 )) 19 . Here we show that the auto-oxidation of RSV is highly dependent on the in tap water (Fig. S4e left) , which might explain further the often-reported perplexing low bioavailability of RSV in vivo [21] [22] [23] . Although RSV could potentially be protected from protein carriers such as serum albumin 24 , the entirety of these data makes it difficult to understand how RSV could exert compound-protein specific effects. These results further indicate that potential metabolisation of RSV, for example by oxidation of the enzymes of the CYP1 family, might play a minor role in physiological context, consistent with the usually extremely low amounts of detected metabolites of resveratrol [21] [22] [23] .
RSV produces ROS under physiologically relevant conditions
We next asked how the oxidising RSV could induce relevant biological effects. As revealed by an antioxidant assay using trolox as control compound, in presence of sodium bicarbonate the anti-oxidative feature of ROSproducing RSV was strongly diminished (Fig. S4f left) . In contrast, RSV showed roughly 2-fold higher anti-oxidative capacity in solvents lacking sodium bicarbonate (Fig. S4f right) . These data suggest that RSV loses in part its anti-oxidative properties and becomes more pro-oxidative in physiological media containing sodium bicarbonate.
These data indicate that oxidation of RSV takes place under physiologically relevant conditions that differ significantly from experimental setups applied to analyse RSV by common bicarbonate-free enzymatic assays, or bicarbonate-free crystallization procedures that are mostly used for x-ray analyses. Notably, low concentrations of oxidation products of RSV such as ROS can mildly affect cellular biomolecules such as proteins and lipids ( Figure 1d ).
Effects on primary human keratinocytes
We next asked how oxidation of RSV might influence physiological effects. Given the here observed oxidative effects in particular topological application of RSV seems a medially relevant approach, as is evident from the number of available dermatological products based on RSV. We thus focused in this study on potential protection of the human epidermis. Notably, due to ethical considerations and law, for physiological testing dermatological research applies ex vivo models such as the here used primary human keratinocytes that form the outer layer of the skin. Keratinocytes are known to build a tight layer of cells that can be used as epidermal grafts ( Fig.   S4g ) 25 , and these cells represent a prime target for lotions and emollients based on Moreover, to globally monitor cellular response to oxidation products of RSV, genome-wide RNA expression analyses revealed a slight but significantly increased expression of molecular pathways covering oxidative stress response and inflammatory signalling, as well as fatty acid metabolism ( Figure 1e and Table S2 ). In contrast, processes linked to proliferation, DNA replication and cell cycle were downregulated. Importantly, quenching of oxidation by adding strong reducing molecules such as 25 mM synthetic GSH significantly reversed expression of cell response marker genes ( Figure 1f ). As shown in a control experiment, quenching by synthetic GSH in reduced the levels of ROS derived from RSV in cell-free environment (Fig .   S4g ) and even more importantly within cells (Fig. S4i) , suggesting that ROS derived from RSV mainly cause the observed gene expression effects. As tested with a small panel of unrelated cell models, despite cell-specific defence mechanisms the here observed gene expression events seem to some degree be independent from cellular background (Fig S5a-d , Table S3 ).
These data indicate to our knowledge for the first time that major gene expression events induced by RSV can be explicitly attributed to the development of oxidation products of RSV such as ROS, since depletion by molecular quenchers strongly truncated cellular response. The effects of RSV analysed here in mammalian cells might also underlie phytoalexin-based protection of plants against microbial infection 28 .
Oxidative products of RSV cause hormetic effects
In a next step, we asked how oxidation products derived from RSV could potentially influence viability of cells. Using common cell viability assays, we observed increased cellular fitness up to about 50 µM RSV in treated NHEKs, whereas higher concentrations tend to produce toxic effects, leading to a typical bi-phasic, hormetic dose-viability curve (Figure 2a and b) . Notably, in additional cellular models for fibroblasts and liver we observed similar bi-phasic dose-viability curves as for NHEK cells but (depending on the cell model) varying susceptibility to oxidative products Importantly, the hormetic dose-viability curve was strongly truncated by adding 25 mM synthetic GSH as a quencher, providing to our knowledge for the first time strong evidence that increased viability of cells after RSV treatment mainly derived from ROS and related products of RSV (Figure 2a-d) . In other words, the mechanism of action of RSV to slightly improve cellular fitness seems to rely significantly on oxidative effects of RSV, resulting in a bi-phasic, concentration-dependent cellular response. In summary, the here proposed link introduces an explicit explanation of the so far rather "nebulous" hormetic effects of RSV.
Hormetic effects of oxidative products derived from RSV are driven by activation of Nrf2
We next asked how oxidising RSV could induce any specific molecular response in a cellular context. Especially the nuclear factor (erythroid-derived 2) like 2 (Nrf2) is considered responsible for accommodating oxidative stress 2, [29] [30] [31] . Consistent with the above shown production of oxidation products of RSV, we observed translocation of redox-sensitive Nrf2 into the nucleus of NHEKs (Figure 3e and In the context of increasing autophagy and overall molecular stress, this mechanism might allow cells to focus their limited resources on cellular repair, while decreasing cellular proliferation and nucleotide synthesis (Figure 1e) . Notably, similar effects were observed for mild stress such as calorie restriction to improve cellular fitness 33, 34 . Evidently, many of the effects described appear to be specifically mediated via activation of the redox-sensitive transcription factor Nrf2. We next asked if and how other reported factors such as the promiscuously reacting deacetylase SIRT1 could potentially modulate the effects derived from RSV-based activation of Nrf2, for example in the context of autophagy.
As shown above, under physiologically relevant conditions the almost completely degraded RSV can merely directly or allosterically induce the enzymatic activity of SIRT1 (Fig. S1e) . However, the 4-fold up-regulation of SIRT1 expression ( Figure   3b ), the phosphorylated SIRT1 ( (Fig. S7b) . However, at least in NHEKs -in contrast to knockdown of NRF2 -knockdown of SIRT1 did not strongly influence overall gene or protein expression ( Fig. S7c and d) , corroborating the major role of Nrf2 in the response to oxidative products such as ROS derived from RSV.
Oxidative products of RSV induce a reduced cellular redox environment
We then asked how gene expression mediated by RSV/ROS-based activation of Nrf2 might influence cellular metabolism. In NHEKs treated for 16 hours with 50 µM RSV, we observed phosphorylation signalling events such as increased phosphorylation of pyruvate dehydrogenase E1 component subunit alpha (PDE1α) at serine 293 (Fig. S8a) , an effect known to inhibit endogenous pyruvate breakdown and oxidative phosphorylation 35 . Consequently, this molecular effect led to increased intracellular levels of the potential ROS-scavenger pyruvate while lactate remained at constant levels ( Figure 5a ). Under constant mitochondrial biogenesis (Fig. S8b) , we further observed decreased mitochondrial oxygen consumption during 16 hours of RSV treatment (Fig. S8c) .
Moreover, the intracellular ratio of metabolite couples 2GSH/GSSG and ATP/ADP as well as the amount of glucose significantly increased (Figure 5a and In summary, these data indicate a metabolic switch that leads amongst others to an increased pool of reduced glutathione. Clearly, the GSH concentration can vary a lot between different cells, depending on stress exposure and function 36 .
We next analysed the redox environment of NHEKs treated with RSV using intracellular concentrations of above-mentioned key metabolites, using the formula (Eq. 1)
Indeed, RSV treatment at hormetic concentrations shifted the cellular redox environment to a more reduced state mediated by Nrf2 (Figure 5c and for calculationrelevant parameters Table S4 ) 37 . Based on the 2GSH/GSSG couple, which provides the by far largest pool of reducing equivalents 36 , we calculated a slight shift of redox Table S4 ).
According to our results, RSV treatment can contribute to an overall reduction of biological molecules containing for example thiol groups, as evident from the increased cellular GSH concentration ( Figure 5a ).
We then analysed if the observed reduced redox environment could potentially protect the cell from (oxidative) stress. Therefore, we subjected NHEKs to 16 hours pretreatment with 50 µM RSV. After replacement of medium the NHEK cells were devoid of any residual RSV. We then treated NHEKs with ~0.8% ethanol and analysed the endogenous generation of intracellular ROS from cellular metabolisation of ethanol, i.e. the level of oxidative stress (Figure 5d ) 38 . Notably, we observed that overall reduced cellular environment (owing to the observed increased pool of endogenous GSH) enabled RSV-pre-treated NHEKs to buffer the additional production of ROS due to biotransformation of ethanol (Figure 5d ). The protective effects of pre-treatment with RSV were revised in a concentration-dependent manner by addition of 4-hydroxy-2-nonenal (HNE), an α,β-unsaturated aldehyde, which amongst others acts as a strong electrophile by depleting cellular sulfhydryl compounds like GSH (Figure 5d ) 39 .
Summarizing, we propose a bi-phasic pharmacological model for RSV, which might Clearly, the here proposed model largely depends on the pro-and anti-oxidative properties of RSV in a given microenvironment. We argue that bicarbonate containing media are essential for living systems, and thus it seems that our model might be extendable to a large variety of biological phenomena. Our data indicate at least that proper analysis of the potential pro-and anti-oxidative features of RSV in a specific experimental set-up shall be thoroughly explored prior any biological investigation to define a common basis and thereby avoid any potential misinterpretation.
In particular the human epidermis being predominantly prone to external stress might benefit from dermatological application of RSV. The here elaborated pro-oxidative features of RSV and the redox-environment shifting concept can fully explain such recent claims 31 . Of note, whereas RSV might remain stable under low pH conditions in the stomach ( Fig. S2 and 3 ), physiologically well-known neutralization in the 11 . CC-BY-ND 4.0 International license not peer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was . http://dx.doi.org/10.1101/045567 doi: bioRxiv preprint first posted online Mar. 24, 2016; duodenum -by high concentrations of bicarbonate derived from the pancreas -might induce so far largely unexplored pro-oxidative features of RSV in the intestine.
Considering reduction of the cellular redox environment as the main physicochemical mechanism, the often-reported weak and pleiotropic effects of RSV can be quantitatively determined using molecular data of redox-relevant metabolites and the above formula (Eq. 1; see also Figure 5c and Table S4 ). On the other hand, in particular the effects derived from oxidation products with short lifetimes such as ROS are difficult to trace in vitro and in particular in vivo. This drawback might provoke scepticism how such "dirty" chemicals shall exert well-controllable cellular and physiological effects.
Nevertheless, taking a systems view we suggest to apply the here explored paradigm for mathematically analysing the emerging relevant biological effects of "dirty"
compounds. This approach allows amongst others calculating the oxidation-buffering capacity of targeted cells under investigation. Using such a framework, development of chemical derivatives of RSV and of molecular carriers might be helpful to rationally exploit the beneficial bi-phasic effects of pro-oxidative compounds for therapeutic and preventive application.
In general, hormetic induction of cellular fitness by physiologically pro-oxidative polyphenols such as RSV might represent a powerful approach to protect cells against physiological stress and to inhibit age-related diseases. Technologies), 70 µM calcium chloride (Merck GmbH, Darmstadt, Germany), 100 U/ml penicillin and 100 µg/ml streptomycin.
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All cell lines were maintained at 37°C in a humidified 5% CO 2 . Primer sequences are summarized in Table S5 . Data were analysed using GraphPad Prism 5.0.
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. Data were analysed using GraphPad Prism 5.0.
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Genome-wide gene expression analyses
Genome-wide gene expression analyses were done by ATLAS Biolabs GmbH (Berlin, Germany) on HumanHT-12 Expression BeadChips (Illumina, Eindhoven, The Netherlands). All basic expression data analyses were carried out using GenomeStudio V2011.1 (Illumina). Raw data were background-subtracted and normalized using the cubic spline algorithm. Processed data were filtered for significant detection (P value ≤ 0.01) and differential expression vs. vehicle treatment according to the Illumina t-test error model and were corrected according to the Benjamini-Hochberg procedure (P value ≤ 0.05) in the GenomeStudio software. Gene expression data were submitted to the Gene Expression Omnibus database (GSE72119).
Gene Set Enrichment Analysis (GSEA) 42 of the RSV gene expression profiles was performed using the following parameters: 1000 gene set permutations, weighted enrichment statistic, and signal-to-noise metric. Microarray data were analysed using the curated C2 KEGG pathways gene sets (version 4.0, 186 gene sets) from the Molecular Signature Database (MSigDB) ( Table S2) . Lifetime, dual-delay and gate times were calculated and set according to the manufacturer's instructions. Data were analysed using GraphPad Prism 5.0.
24
. Redox potential, redox state and redox environment To calculate the half-cell reduction potential of a selected redox couple the Nernst equation (Eq. 2) was used and transformed to match the experimental conditions (T = 310K = 37°C, pH 7) (Eq. 3). ) is pH dependent, an adjustment is necessary:
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E pH represents the half-cell reduction potential at a given pH, while ΔE/ΔpH is dependent on the number of electrons and protons involved. Finally, the half-cell reduction potential of a selected redox couple can be calculated according to (Eq. 5).
The half-cell reduction potential can be calculated for the following metabolites (redox couples):
Eq. 8
Eq. 9
Eq. 10
Finally the redox environment is calculated using the redox couple 2GSH/GSSG alone ( Figure 5a and Table S4 ) or redox couples lactate/pyruvate, NADH/NAD + and 2GSH/GSSG (Fig. S8f and Table S4 ), respectively.
To relate the reduced redox environment to a future oxidative challenge, we did a thought experiment focusing on oxidation of ethanol to acetaldehyde and simultaneous ROS generation [7] [8] [9] :
Eq. 11
In order to estimate the amount of ethanol caused ROS generation, which can be quenched by RSV pre-treatment, we made the following assumptions:
• pH 7,
• T = 37°C,
• 2GSH/GSSG redox couple is the driving force of the redox environment and
• Concentrations of GSH and GSSG as measured at pH 7.0026 (vehicle) and 7.0632 (RSV), respectively.
At equilibrium, change of the half-cell reduction potentials of both couples equal 0 and can be transformed appropriately:
Eq. 12 
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. At low concentrations oxidising RSV induces mild stress, resulting in a metabolic and redox environment shift to increase the level of endogenous quenchers to eventually protect the cell from environmental stress.
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